Enanta Pharmaceuticals reported $55.47M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Acorda Therapeutics ACOR:US $ 47.47M 10.17M
Amgen AMGN:US $ 5.7B 1.93B
Anika Therapeutics ANIK:US $ 28.96M 4.07M
Arrowhead Research ARWR:US $ 77.76M 16.72M
AstraZeneca AZN:LN 7.09B 1.67B
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biogen BIIB:US $ 2289.3M 569.2M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Clovis Oncology CLVS:US $ 94.4M 1.66M
Enanta Pharmaceuticals ENTA:US $ 55.47M 5.64M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Halozyme Therapeutics HALO:US $ 43.41M 15.84M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Insmed INSM:US $ 151.62M 27.57M
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Ligand Pharmaceuticals LGND:US $ 38.94M 16.3M
Marinus Pharmaceuticals MRNS:US $ 25.39M 3.58M
Merk MRK:US $ 9905M 839M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NOVN:VX 9.82B 464M
Novavax NVAX:US $ 643.85M 12.01M
Pfizer PFE:US $ 13063M 3998M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Vital Therapies VTL:US $ 19.17M 13.22M
YTE INCY:US $ 564.87M 58.95M